Etiology of stroke and choice of models

International Journal of Stroke

Volumn 7, Issue 5, 2012, Pages 398-406

  Krafft, Paul R ^a   Bailey, Emma L ^b   Lekic, Tim ^a   Rolland, William B ^a   Altay, Orhan ^a   Tang, Jiping ^a   Wardlaw, Joanna M ^b   Zhang, John H ^a   Sudlow, Cathie L M ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Animal models; Intracerebral hemorrhage; Ischemic stroke; Rodent; Stroke subtypes; Sub arachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT; NIMODIPINE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN SIZE; COMORBIDITY; COST; DISEASE MODEL; DISEASE SEVERITY; EXPERIMENTAL ANIMAL; GRAY MATTER; HUMAN; MICROVASCULARIZATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROANATOMY; NEUROLOGIC EXAMINATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; RODENT; SMALL VESSEL VASCULITIS; STROKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SUBARACHNOID HEMORRHAGE; TRANSGENIC ANIMAL; WHITE MATTER;

ANIMALS; ANIMALS, INBRED STRAINS; BRAIN ISCHEMIA; CHOICE BEHAVIOR; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; RATS; RESEARCH DESIGN; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 84862683556     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00838.x     Document Type: Review

References (97)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747-1757.
2. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke (Lancet seminar series). Lancet 2003; 362:1211-1224.
3. Al-Shahi Salman R, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ 2009; 339:b2586.
4. Al-Shahi R, White PM, Davenport RJ, Lindsay KW. Subarachnoid haemorrhage. BMJ 2006; 333:235-240.
5. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003; 2:43-53.
6. Nieuwkamp DJ, Setz LE, Algra A, Linn FHH, de Rooij NK, Rinkel GJE. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009; 8:635-642.
7. Sudlow C, Warlow C. Getting the priorities right for stroke care. BMJ 2009; 338:b2083.
8. Sudlow C. Preventing further vascular events after a stroke or transient ischaemic attack: an update on medical management. Pract Neurol 2008; 8:141-157.
9. Ezzati M, Van der Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJL, Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362:271-280.
10. O'Collins VE, Macleod MR, Donnan GA etal. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006; 59:467-477.
11. van der Worp HB, Howells DW, Sena ES etal. Can animal models of disease reliably inform human studies? PLoS Med 2010; 7:e1000245. doi:10.1371/journal.pmed.1000245.
12. Bailey EL, McCulloch J, Sudlow CL, Wardlaw JM. Potential animal models of lacunar stroke. A systematic review. Stroke 2009; 40:e451-458.
13. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10:267-272.
14. Schmidt-Kastner R, Paschen W, Ophoff BG, Hossmann KA. A modified four-vessel occlusion model for inducing incomplete forebrain ischemia in rats. Stroke 1989; 20:938-946.
15. Xu ZC, Pulsinelli WA. Responses of CA1 pyramidal neurons in rat hippocampus to transient forebrain ischemia: an in vivo intracellular recording study. Neurosci Lett 1994; 171:187-191.
16. Yamaguchi M, Calvert JW, Kusaka G, Zhang JH. One-stage anterior approach for four-vessel occlusion in rat. Stroke 2005; 36:2212-2214.
17. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 1984; 69:385-401.
18. Hendrickx HH, Rao GR, Safar P, Gisvold SE. Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. Resuscitation 1984; 12:97-116.
19. Katz L, Ebmeyer U, Safar P, Radovsky A, Neumar R. Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 1995; 15:1032-1039.
20. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res 1998; 792:105-113.
21. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004; 35:2598-2603.
22. Kuge Y, Minematsu K, Yamaguchi T, Miyake Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke 1995; 26:1655-1658.
23. Hata R, Mies G, Wiessner C etal. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18:367-375.
24. Tureyen K, Vemuganti R, Sailor KA, Dempsey RJ. Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery 2005; 56:196-200; discussion 196-200.
25. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 1975; 255:332-334.
26. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1:53-60.
27. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42:289-298.
28. Kilic E, Hermann DM, Hossmann KA. A reproducible model of thromboembolic stroke in mice. Neuroreport 1998; 9:2967-2970.
29. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985; 17:497-504.
30. Futrell N, Watson BD, Dietrich WD, Prado R, Millikan C, Ginsberg MD. A new model of embolic stroke produced by photochemical injury to the carotid artery in the rat. Ann Neurol 1988; 23:251-257.
31. Nagai N, Zhao BQ, Suzuki Y, Ihara H, Urano T, Umemura K. Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice. J Cereb Blood Flow Metab 2002; 22:648-651.
32. Toshima Y, Satoh S, Ikegaki I, Asano T. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor. Stroke 2000; 31:2245-2250.
33. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995; 26:1086-1092.
34. Veelken JA, Laing RJ, Jakubowski J. The Sheffield model of subarachnoid hemorrhage in rats. Stroke 1995; 26:1279-1284.
35. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke 1985; 16:58-64.
36. Suzuki H, Kanamaru K, Tsunoda H etal. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999; 104:59-66.
37. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990; 21:801-807.
38. Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial haemorrhage induced at arterial pressure in the rat. Part 1: description of technique, ICP changes and neuropathological findings. Neurol Res 1984; 6:184-188.
39. Belayev L, Saul I, Curbelo K etal. Experimental intracerebral hemorrhage in the mouse: histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003; 34:2221-2227.
40. Bailey EL, Smith C, Sudlow CLM, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of subcortical ischaemic stroke? A systematic review. Int J Stroke 2011; 6:434-444.
41. Collidge TA, Lammie GA, Fleming S, Mullins JJ. The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 2004; 84:301-319.
42. Iida S, Baumbach GL, Lavoie JL, Faraci FM, Sigmund CD, Heistad DD. Spontaneous stroke in a genetic model of hypertension in mice. Stroke 2005; 36:1253-1258.
43. James ML, Warner DS, Laskowitz DT. Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care 2008; 9:139-152.
44. Green AR, Cross AJ. Techniques for examining neuroprotective drugs in vivo Int Rev Neurobiol 1997; 40:47-68.
45. Traystman RJ. Animal models of focal and global cerebral ischemia. ILAR J 2003; 44:85-95.
46. Titova E, Ostrowski RP, Zhang JH, Tang J. Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res 2009; 31:568-581.
47. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989; 20:1627-1642.
48. Lim C, Alexander MP, LaFleche G, Schnyer DM, Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology 2004; 63:1774-1778.
49. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341:c3666.
50. Wellons JC 3rd, Sheng H, Laskowitz DT, Burkhard Mackensen G, Pearlstein RD, Warner DS. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res 2000; 868:14-21.
51. del Zoppo GJ, Poeck K, Pessin MS etal. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
52. Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 2007; 203:555-567.
53. Freret T, Bouet V, Leconte C etal. Behavioral deficits after distal focal cerebral ischemia in mice: usefulness of adhesive removal test. Behav Neurosci 2009; 123:224-230.
54. Winter B, Bert B, Fink H, Dirnagl U, Endres M. Dysexecutive syndrome after mild cerebral ischemia? Mice learn normally but have deficits in strategy switching. Stroke 2004; 35:191-195.
55. Gerlai R, Thibodeaux H, Palmer JT, van Lookeren Campagne M, Van Bruggen N. Transient focal cerebral ischemia induces sensorimotor deficits in mice. Behav Brain Res 2000; 108:63-71.
56. Lee SU, Kim DY, Park SH, Choi DH, Park HW, Han TR. Mild to moderate early exercise promotes recovery from cerebral ischemia in rats. Can J Neurol Sci 2009; 36:443-449.
57. Hu X, Zheng H, Yan T etal. Physical exercise induces expression of cd31 and facilitates neural function recovery in rats with focal cerebral infarction. Neurol Res 2010; 32:397-402.
58. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-2758.
59. Kudo M, Aoyama A, Ichimori S, Fukunaga N. An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke 1982; 13:505-508.
60. Kaneko D, Nakamura N, Ogawa T. Cerebral infarction in rats using homologous blood emboli: development of a new experimental model. Stroke 1985; 16:76-84.
61. Orset C, Macrez R, Young AR etal. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 2007; 38:2771-2778.
62. Brinker G, Franke C, Hoehn M, Uhlenkuken U, Hossmann KA. Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport 1999; 10:3269-3272.
63. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 1994; 6:257-286.
64. Zhang L, Zhang ZG, Zhang C, Zhang RL, Chopp M. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke 2004; 35:2890-2895.
65. Tanaka Y, Imai H, Konno K etal. Experimental model of lacunar infarction in the gyrencephalic brain of the miniature pig: neurological assessment and histological, immunohistochemical, and physiological evaluation of dynamic corticospinal tract deformation. Stroke 2008; 39:205-212.
66. Thal SC, Mebmer K, Schmid-Elsaesser R, Zausinger S. Neurological impairment in rats after subarachnoid hemorrhage - a comparison of functional tests. J Neurol Sci 2008; 268:150-159.
67. Germano AF, Dixon CE, d'Avella D, Hayes RL, Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 1994; 11:345-353.
68. Silasi G, Colbourne F. Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 2009; 198:380-387.
69. Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ. Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 1990; 72:559-566.
70. Frazer D, Ahuja A, Watkins L, Cipolotti L. Coiling versus clipping for the treatment of aneurysmal subarachnoid hemorrhage: a longitudinal investigation into cognitive outcome. Neurosurgery 2007; 60:434-442.
71. Lanzino G, Kassell NF, Germanson TP etal. Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg 1996; 85:410-418.
72. Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: an international population-based study. Neurology 2000; 55:658-662.
73. MacLellan CL, Silasi G, Poon CC etal. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008; 28:516-525.
74. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 1998; 89:991-996.
75. Hartman R, Lekic T, Rojas H, Tang J, Zhang JH. Assessing functional outcomes following intracerebral hemorrhage in rats. Brain Res 2009; 1280:148-157.
76. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344:1450-1460.
77. MacLellan CL, Silasi G, Auriat AM, Colbourne F. Rodent models of intracerebral hemorrhage. Stroke 2010; 41:S95-98.
78. Auriat AM, Colbourne F. Delayed rehabilitation lessens brain injury and improves recovery after intracerebral hemorrhage in rats. Brain Res 2009; 1251:262-268.
79. Auriat AM, Wowk S, Colbourne F. Rehabilitation after intracerebral hemorrhage in rats improves recovery with enhanced dendritic complexity but no effect on cell proliferation. Behav Brain Res 2010; 214:42-47.
80. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 2008; 28:1877-1891.
81. Bailey EL, Wardlaw JM, Graham D, Dominiczak AF, Sudlow CLM, Smith C. Cerebral small vessel endothelial structural changes predate hypertension in stroke prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5-21 weeks old rats. Neuropathol Appl Neurobiol 2011; 37:711-726.
82. Wardlaw J, Doubal F, Armitage P etal. Lacunar stroke is associated with diffuse blood brain barrier dysfunction. Ann Neurol 2009; 65:194-202.
83. Hassan A, Hunt BJ, O'Sullivan M etal. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126:424-432.
84. Garosi L, McConnell JF, Platt SR etal. Clinical and topographic magnetic resonance characteristics of suspected brain infarction in 40 dogs. J Vet Intern Med 2006; 20:311-321.
85. Rossmeisl JH Jr, Rohleder JJ, Pickett JP, Duncan R, Herring IP. Presumed and confirmed striatocapsular brain infarctions in six dogs. Vet Ophthalmol 2007; 10:23-36.
86. Markus HS. Stroke genetics. Hum Mol Genet 2011; 20:R124-131.
87. Ayata C. CADASIL: experimental insights from animal models. Stroke 2010; 41:S129-134.
88. Joutel A, Monet-Leprêtre M, Gosele C etal. Cerebrovascular dysfunction and microcirculaton rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 2010; 120:433-445.
89. Wiebers DO, Adams HP Jr, Whisnant JP. Animal models of stroke: are they relevant to human disease? Stroke 1990; 21:1-3.
90. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87:179-197.
91. Takizawa S, Hogan M, Hakim AM. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 1991; 11:786-793.
92. Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx 2006; 3:497-504.
93. DeVries AC, Nelson RJ, Traystman RJ, Hurn PD. Cognitive and behavioral assessment in experimental stroke research: will it prove useful? Neurosci Biobehav Rev 2001; 25:325-342.
94. Jeon H, Ai J, Sabri M etal. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci 2009; 10:103.
95. MacLellan CL, Auriat AM, McGie SC etal. Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J Cereb Blood Flow Metab 2006; 26:1031-1042.
96. NINDS. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 2005; 36:e23-41.
97. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-2758.